Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
about
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerRole of EMT in Metastasis and Therapy ResistanceEMT-Inducing Molecular Factors in Gynecological CancersDNA methylation changes in epithelial ovarian cancer histotypes.Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cellDNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.Sfrp5 modulates both Wnt and BMP signaling and regulates gastrointestinal organogenesis [corrected] in the zebrafish, Danio rerio.Wnt pathway activity in breast cancer sub-types and stem-like cellsEpigenetic regulation of cancer-associated genes in ovarian cancer.p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancerGene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthThe pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways.Epithelial-mesenchymal transition in ovarian carcinomaSecreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform.Silencing of Wnt5a during colon cancer metastasis involves histone modifications.Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes.Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer.Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.NKX6.1 functions as a metastatic suppressor through epigenetic regulation of the epithelial-mesenchymal transitionIntegration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cellsComprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkersRole of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca2+ pathways in cisplatin-induced chemoresistance in ovarian cancer.Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.Secreted frizzled related protein 1 modulates taxane resistance of human lung adenocarcinoma.MiR-490-3p sensitizes ovarian cancer cells to cisplatin by directly targeting ABCC2.Physiological inhibitors of Wnt signaling.Role of canonical Wnt signaling in endometrial carcinogenesis.Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.
P2860
Q26747651-79248CAD-96F1-4E44-A294-E7BB347781B6Q26772923-ECB46634-1FDB-4837-9082-BE9A3FBD9CAEQ26781912-1B02E876-492C-45A7-AAB3-0E2F021063A5Q27690722-C5D07215-8D9E-4ADA-B137-297432374BDEQ28478564-75D848E0-96CC-4E34-933E-D6D18FC0A15DQ33799002-6DBC8F92-52A5-4E86-B415-C947184101C5Q34449657-07792395-EE24-48F1-B718-56C4B82DBAE8Q34504817-33B6E898-C59A-48CD-88D6-D64A1D3E14B0Q34701562-B06B8A82-CDE2-4F7C-994A-D44431508D00Q34826223-6147B84C-0788-4194-91DD-589895701FCBQ34874813-0D24A5FF-3DEC-4848-8E42-4BB7C5238B2BQ34887682-8B639313-0304-4F20-B5C8-7EE48A23C067Q35137818-D0BF12EA-EC86-48F7-A5BD-DB17CD4676EFQ35273654-58735D38-C1FB-4A8C-AF60-0AFF3B299839Q35281886-1D8719E4-ACB0-4888-94C2-F8BBE8599D6CQ35793711-62ADBF12-875A-454C-8801-5846630DC0AEQ35837949-25284B5A-082D-4242-8C17-AAA9E494575AQ35971814-A8D1BC2E-587B-4867-BC89-3F57E55F989FQ36068357-A3841FF9-F3D2-4998-9F24-85449D6635F3Q36088140-DBFCFFFC-55AA-4531-A6A0-6C2E9E004242Q36100968-99B52FAB-B4EF-463C-903B-AFA04E18CB92Q36105474-72ADE23B-4902-4F79-BF71-2572A77B35F7Q36201267-4CE15EFD-C3B4-4D3F-8C1A-2CA3F32F4798Q36471888-2A39E006-6F32-4A1A-A432-444911175E19Q36545609-DED81A96-F653-4CC2-BF65-C0962B920413Q36864408-B970AB76-67F0-4FD9-BA7D-ED1A6FB8C395Q37000936-7B02CB64-34D7-408F-AB6E-44E438F961EAQ37103452-3026801B-61BD-49E7-A2B4-6579262B4C7CQ37378675-3D0B9022-D5E6-4135-BFF3-4F6F2851316FQ37582011-08A4C68A-2674-424F-891C-9ADCBB4F4E58Q37606422-E7A2D019-198E-461E-A8FA-E5A17F11F0F5Q37684607-4457EFF3-ADC0-4705-BAD4-BCB226266968Q37719572-79899501-BF09-4FB1-B391-9485C3514CE8Q37728993-7A2ACA00-6669-46B6-A075-2940BE9ECC94Q37732994-3743309C-5326-4814-9E0D-70656BD08975Q37845920-36C0CCB1-4210-42C4-A6A0-12AF1324616BQ37965633-2C103408-3138-490D-8CD6-C987B7A6C3E1Q38024791-A403A7CC-1378-418F-8166-44046C2BB25EQ38544386-EF06EE1C-DDC4-4CEE-87E3-8859A076C42DQ38965179-FF687BB8-D21A-4752-A2D1-609EBF2462ED
P2860
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@ast
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en-gb
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@nl
type
label
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@ast
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en-gb
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@nl
prefLabel
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@ast
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en-gb
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@nl
P2093
P921
P3181
P356
P1476
Epigenetic silencing of SFRP5 ...... through Wnt signaling pathway
@en
P2093
Chi-Kuan Chen
Chin-Yun Liu
Her-Young Su
Hsin-Yi Lee
Hung-Cheng Lai
Mu-Hsien Yu
Shin-Ping Lin
Wen-Chi Lin
Ya-Wen Lin
Yu-Ching Chou
P2860
P304
P3181
P356
10.1002/IJC.25083
P407
P577
2010-08-01T00:00:00Z